Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

ClinicalTrials.gov ID: NCT00248183

Public ClinicalTrials.gov record NCT00248183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 4:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Tolerability Of PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in adults with GAD. Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who fulfill the inclusion/exclusion criteria, will be enrolled in this study.

Study identification

NCT ID
NCT00248183
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Epix Pharmaceuticals, Inc.
Industry
Enrollment
310 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Not listed
Completion
May 31, 2006
Last update posted
Apr 2, 2008

2005 – 2006

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Vista Medical Research Mesa Arizona 85206
Pivotal Research Center Mesa Arizona 85210
Anaheim Research Center Anaheim California 92801
Pacific Clinical Research Group Upland California 91739
Connecticut Clinical Research Cromwell Connecticut 06416
The George Washington University Washington D.C. District of Columbia 20037
Gulf Coast Clinical Research Center Fort Myers Florida 33912
Atlanta Institute of Research and Medicine Atlanta Georgia 30328
Northwest Behavioral Research Marietta Georgia 30060
Louisiana Research Associates New Orleans Louisiana 70114
Pivotal Research Center Royal Oak Michigan 48073
Comprehensive Neurosciences Kenilworth New Jersey 07033
Mount Sinai School of Medicine New York New York 10029
Oregon Center for Clinical Investigations Portland Oregon 97210
Oregon Center for Clinical Investigations Salem Oregon 97301
Unversity of Pennsylvania Philadelphia Pennsylvania 19140
Future Search Trials Austin Texas 78756
UT Southwestern Medical Center Dallas Texas 75235
Comprehensive Neurosciences Falls Church Virginia 22041
Sidney Lerfald, MD Charleston West Virginia 25301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Anxiety Disorders trials

Other public records listing Anxiety Disorders. Sorted by last update posted; newest first. Not a recommendation.

All Anxiety Disorders trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00248183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2008 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00248183 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →